{"product_id":"enflon-empaglifliozin-10mg-3","title":"Enflon (Empaglifliozin)","description":"\u003cul\u003e\r\n \t\u003cli\u003e\r\n\u003ch3\u003eBrand name: Enflon.\u003c\/h3\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003ch3\u003eGeneric name: Empaglifozin.\u003c\/h3\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003ch3\u003eStrength: 4oomg+100mg\u003c\/h3\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\r\n\u003ch3\u003eDosage form: Tablet\u003c\/h3\u003e\r\n\r\n\u003chr\u003e\r\n\r\n\u003cstrong\u003eIndications\u003c\/strong\u003e\r\n\r\nEnpagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor; suitable for:\r\n\u003cul\u003e\r\n \t\u003cli\u003eAs an aid to diet and exercise to improve blood sugar control in adults with type 2 diabetes.\u003c\/li\u003e\r\n \t\u003cli\u003eReduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular diseases.\u003c\/li\u003e\r\n \t\u003cli\u003eRestrictions on use: Not applicable to the treatment of patients with type 1 diabetes or diabetic ketoacidosis.\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eDose and administration method\u003c\/strong\u003e\r\n\u003col\u003e\r\n \t\u003cli\u003eMethod of administration\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eRecommended dosage of empagliflozin: 10mg once a day, taken in the morning, with or without food.\u003c\/li\u003e\r\n \t\u003cli\u003eThe dose can be increased to 25mg once a day.\u003c\/li\u003e\r\n \t\u003cli\u003eBefore taking empagliflozin, renal function needs to be assessed, and the glomerular filtration rate eGFR is estimated to be lower than Patients with 45ml\/min\/1.73m2 should not take empagliflozin. If the eGFR value of glomerular filtration rate is estimated to be less than 45ml\/min\/1.73m2 during taking, you should Stop the drug.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003col start=\"2\"\u003e\r\n \t\u003cli\u003eDosage specifications\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eTablets, 10mg, 25mg.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003col start=\"3\"\u003e\r\n \t\u003cli\u003eContraindications: patients with a history of severe hypersensitivity to Enpagliflozin should not take it; severe renal impairment, renal Patients with terminal illness or dialysis should not take it.\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/li\u003e\r\n\u003c\/ol\u003e\r\n\u003cstrong\u003eWarnings and Precautions\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003eHypotension: In patients with renal impairment, elderly patients, patients with low systolic blood pressure, and taking\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nIn diuretic patients, before starting to take empagliflozin, renal volume contraction should be evaluated and corrected\r\n\r\nstate. During the administration period, closely monitor the signs and symptoms of hypotension.\r\n\u003cul\u003e\r\n \t\u003cli\u003eKetoacidosis: Regardless of the level of blood sugar, patients with ketoacidosis must evaluate before taking it.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nAssess the signs and symptoms of metabolic ketoacidosis in patients. If ketoacidosis is suspected, stop the drug in time and suffer\r\n\r\nReassess the patient and start treatment in time. Before taking empagliflozin, consider the triggering factor of ketoacidosis and take\r\n\r\nEnpagliflozin patients may need to temporarily stop if they are monitored for possible ketoacidosis during treatment\r\n\r\n(Please read this notice carefully and take the medicine according to this notice or under the guidance of a doctor)\r\n\r\nmedicine.\r\n\u003cul\u003e\r\n \t\u003cli\u003eAcute kidney injury and renal impairment: consider temporary interruption to reduce oral intake or fluid loss. Such as\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nIf acute kidney injury occurs, stop and treat immediately. Monitor renal function during treatment.\r\n\u003cul\u003e\r\n \t\u003cli\u003eUremia and pyelonephritis: evaluate the patient’s signs and symptoms of urinary tract infection, if applicable,\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nTreat immediately.\r\n\u003cul\u003e\r\n \t\u003cli\u003eHypoglycemia: Consider reducing the dose of insulin secretagogue or insulin to reduce taking Englita\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\nThe risk of net hour hypoglycemia.\r\n\u003cul\u003e\r\n \t\u003cli\u003eFungal infections of the genital tract: proper monitoring and treatment.\u003c\/li\u003e\r\n \t\u003cli\u003eIncrease in low-density lipoprotein cholesterol (LDL-C): proper monitoring and treatment.\r\n\r\n\u003chr\u003e\r\n\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003eAdverse reactions\u003c\/strong\u003e\r\n\r\nThe most common (≥5% incidence) adverse reactions associated with empagliflozin are urinary tract infections and female reproduction\r\n\r\nOrgan fungal infection.\r\n\r\n\u003chr\u003e\r\n\r\n\u003cstrong\u003estorage method\u003c\/strong\u003e\r\n\r\nStore at 25°C (77°F), and allow an offset of 15°-30°C (59°-86°F).","brand":"Tongmeng (Lao) Pharmaceutical \u0026 Food Co., Ltd.（TLPH）","offers":[{"title":"Default Title","offer_id":44797948297259,"sku":"RL142023090143","price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/1655109373-23473a843a4311f.png?v=1787022112","url":"https:\/\/xomeds.com\/products\/enflon-empaglifliozin-10mg-3","provider":"XOMEDS","version":"1.0","type":"link"}